#BEGIN_DRUGCARD DB02686

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C23H44O11

# Chemical_IUPAC_Name:
(2R,3S,4R,5R,6S)-2-{[(2S,3S,4S,5S,6S)-4,5-dihydroxy-2-(hydroxymethyl)-6-(undecyloxy)oxan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Undecyl-Beta-D-Maltopyranoside

# HET_ID:
UMQ

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C23H44O11/c1-2-3-4-5-6-7-8-9-10-11-31-22-20(30)18(28)21(15(13-25)33-22)34-23-19(29)17(27)16(26)14(12-24)32-23/h14-30H,2-13H2,1H3/t14-,15-,16-,17+,18-,19-,20-,21+,22-,23+/m0/s1

# InChI_Key:
InChIKey=UYEMNFYVTFDKRG-LGCFCJMNSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
2686

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
496.5889

# Molecular_Weight_Mono:
496.28836225

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
2BL2

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
1.02

# Predicted_LogS:
-2.1

# Predicted_Water_Solubility:
3.84e+00 g/l

# Primary_Accession_No:
DB02686

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
46936455

# PubChem_Substance_ID:
46508014

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT03188

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
CCCCCCCCCCCO[C@H]1O[C@@H](CO)[C@@H](O[C@H]2O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:21:23 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Cell membrane
multi-pass membrane protein (Potential)

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
D16334

# Drug_Target_1_GenBank_ID_Protein:
416405

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
ntpK

# Drug_Target_1_Gene_Sequence:
>471 bp
ATGATGGATTATTTGATTACTCAAAATGGTGGAATGGTATTTGCAGTATTAGCGATGGCA
ACAGCAACGATTTTTTCAGGAATCGGGTCTGCTAAAGGCGTTGGAATGACTGGGGAAGCG
GCAGCAGCATTGACGACCAGTCAACCAGAAAAATTCGGACAAGCGTTAATTTTACAATTA
CTTCCAGGTACCCAAGGATTATACGGCTTCGTTATCGCCTTCTTGATTTTTATCAACTTA
GGCAGCGATATGTCTGTCGTTCAAGGATTGAACTTCTTAGGAGCTTCCTTACCGATTGCC
TTTACTGGTTTATTCTCAGGGATCGCTCAAGGGAAGGTTGCAGCTGCTGGTATTCAAATT
CTAGCGAAAAAACCTGAGCATGCAACGAAAGGGATCATTTTTGCTGCGATGGTTGAAACA
TATGCCATCTTAGGTTTCGTTATTTCTTTCTTACTGGTCTTAAATGCGTAA

# Drug_Target_1_General_Function:
Energy production and conversion

# Drug_Target_1_General_References:
8144530	Solioz M, Davies K: Operon of vacuolar-type Na(+)-ATPase of Enterococcus hirae. J Biol Chem. 1994 Apr 1;269(13):9453-9.
8157629	Takase K, Kakinuma S, Yamato I, Konishi K, Igarashi K, Kakinuma Y: Sequencing and characterization of the ntp gene cluster for vacuolar-type Na(+)-translocating ATPase of Enterococcus hirae. J Biol Chem. 1994 Apr 15;269(15):11037-44.
8373385	Kakinuma Y, Kakinuma S, Takase K, Konishi K, Igarashi K, Yamato I: A gene encoding the 16-kDa proteolipid subunit of Enterococcus hirae Na(+)-ATPase complex. Biochem Biophys Res Commun. 1993 Sep 15;195(2):1063-9.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
2631

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
16037

# Drug_Target_1_Name:
V-type sodium ATP synthase subunit K

# Drug_Target_1_Number_of_Residues:
156

# Drug_Target_1_PDB_ID:
2BL2

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00137	ATP-synt_C

# Drug_Target_1_Protein_Sequence:
>V-type sodium ATP synthase subunit K
MMDYLITQNGGMVFAVLAMATATIFSGIGSAKGVGMTGEAAAALTTSQPEKFGQALILQL
LPGTQGLYGFVIAFLIFINLGSDMSVVQGLNFLGASLPIAFTGLFSGIAQGKVAAAGIQI
LAKKPEHATKGIIFAAMVETYAILGFVISFLLVLNA

# Drug_Target_1_Reaction:
ATP + H2O + H+in = ADP + phosphate + H+out

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Involved in ATP-driven sodium extrusion

# Drug_Target_1_SwissProt_ID:
P43457

# Drug_Target_1_SwissProt_Name:
NTPK_ENTHR

# Drug_Target_1_Synonyms:
EC 3.6.3.14
Na(+)- translocating ATPase subunit K
Sodium ATPase proteolipid component

# Drug_Target_1_Theoretical_pI:
7.53

# Drug_Target_1_Transmembrane_Regions:
11-31
60-80
89-109
132-152

#END_DRUGCARD DB02686
